Bavarian Nordic To Take Prostvac Therapeutic Prostate Cancer Vaccine Into Phase III
This article was originally published in The Pink Sheet Daily
Executive Summary
Danish firm won license for the therapy, once held by defunct Therion, in CRADA with NCI.